Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease
Identifieur interne : 003D65 ( Main/Exploration ); précédent : 003D64; suivant : 003D66Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease
Auteurs : Richard Dodel [Allemagne] ; Bengt Jönsson [Suède] ; Jens Peter Reese [Allemagne] ; Yaroslav Winter [Allemagne] ; Pablo Martinez-Martin [Espagne] ; Robert Holloway [États-Unis] ; Cristina Sampaio [Portugal] ; Evžen Růži Ka [République tchèque] ; Graeme Hawthorne [Australie] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Glenn Stebbins [États-Unis] ; Oliver Rascol [France] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2014-02.
Abstract
Health economic studies in Parkinson's disease (PD) have become increasingly common in recent years. Because several methodologies and instruments have been used to assess cost and outcomes in PD, the Movement Disorder Society (MDS) commissioned a Task Force to assess their properties and make recommendations regarding their use. A systematic literature review was conducted to explore the use of those instruments in PD and to determine which should be selected for this review. We assessed approaches to evaluate cost of illness (COI), cost effectiveness, and cost utilities, which include the use of direct (standard gamble, time trade‐off. and visual analogue scales) and indirect instruments to measure health status and utilities. No validated instruments/models were identified for the evaluation of COI or cost‐effectiveness in patients with PD; therefore, no instruments in this group are recommended. Among utility instruments, only a few of these outcome instruments have been used in the PD population, and only limited psychometric data are available for these instruments with respect to PD. Because psychometric data for further utility instruments in conditions other than PD already exist, the standard gamble and time trade‐off methods and the EQ‐5D (a European quality‐of‐life health states instrument) and Health Utility Index instruments met the criteria for scales that are “recommended (with limitations),” but only the EQ‐5D has been assessed in detail in PD patients. The MDS Task Force recommends further study of these instruments in the PD population to establish core psychometric properties. For the assessment of COI, the Task Force considers the development of a COI instrument specifically for PD, like that available for Alzheimer's disease. © 2013 Movement Disorder Society
Url:
DOI: 10.1002/mds.25571
Affiliations:
- Allemagne, Australie, Autriche, Espagne, France, Portugal, Royaume-Uni, République tchèque, Suède, États-Unis
- Angleterre, Bohême centrale, Communauté de Madrid, District de Giessen, Grand Londres, Hesse (Land), Illinois, Midi-Pyrénées, Occitanie (région administrative), Svealand, Tyrol (Land), Victoria (État)
- Chicago, Innsbruck, Londres, Madrid, Marbourg, Melbourne, Prague, Stockholm, Toulouse
- University College de Londres, Université de Melbourne, Université de médecine d'Innsbruck
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001850
- to stream Istex, to step Curation: 001850
- to stream Istex, to step Checkpoint: 000089
- to stream Main, to step Merge: 003E16
- to stream Main, to step Curation: 003D65
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease</title><author><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name></author><author><name sortKey="Jonsson, Bengt" sort="Jonsson, Bengt" uniqKey="Jonsson B" first="Bengt" last="Jönsson">Bengt Jönsson</name></author><author><name sortKey="Reese, Jens Peter" sort="Reese, Jens Peter" uniqKey="Reese J" first="Jens Peter" last="Reese">Jens Peter Reese</name></author><author><name sortKey="Winter, Yaroslav" sort="Winter, Yaroslav" uniqKey="Winter Y" first="Yaroslav" last="Winter">Yaroslav Winter</name></author><author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name></author><author><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name></author><author><name sortKey="Ruzi Ka, Evzen" sort="Ruzi Ka, Evzen" uniqKey="Ruzi Ka E" first="Evžen" last="Růži Ka">Evžen Růži Ka</name></author><author><name sortKey="Hawthorne, Graeme" sort="Hawthorne, Graeme" uniqKey="Hawthorne G" first="Graeme" last="Hawthorne">Graeme Hawthorne</name></author><author><name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation><country>Autriche</country><placeName><settlement type="city">Innsbruck</settlement><region nuts="2" type="region">Tyrol (Land)</region></placeName><orgName type="university">Université de médecine d'Innsbruck</orgName></affiliation></author><author><name sortKey="Stebbins, Glenn" sort="Stebbins, Glenn" uniqKey="Stebbins G" first="Glenn" last="Stebbins">Glenn Stebbins</name></author><author><name sortKey="Rascol, Oliver" sort="Rascol, Oliver" uniqKey="Rascol O" first="Oliver" last="Rascol">Oliver Rascol</name></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:81A07A161F130CB26F7F83520A40996C7826FB8E</idno><date when="2014" year="2014">2014</date><idno type="doi">10.1002/mds.25571</idno><idno type="url">https://api.istex.fr/document/81A07A161F130CB26F7F83520A40996C7826FB8E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001850</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001850</idno><idno type="wicri:Area/Istex/Curation">001850</idno><idno type="wicri:Area/Istex/Checkpoint">000089</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000089</idno><idno type="wicri:doubleKey">0885-3185:2014:Dodel R:measurement:of:costs</idno><idno type="wicri:Area/Main/Merge">003E16</idno><idno type="wicri:Area/Main/Curation">003D65</idno><idno type="wicri:Area/Main/Exploration">003D65</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease</title><author><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Allemagne</country></affiliation></author><author><name sortKey="Jonsson, Bengt" sort="Jonsson, Bengt" uniqKey="Jonsson B" first="Bengt" last="Jönsson">Bengt Jönsson</name><affiliation wicri:level="3"><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Economics, Stockholm School of Economics, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author><author><name sortKey="Reese, Jens Peter" sort="Reese, Jens Peter" uniqKey="Reese J" first="Jens Peter" last="Reese">Jens Peter Reese</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Winter, Yaroslav" sort="Winter, Yaroslav" uniqKey="Winter Y" first="Yaroslav" last="Winter">Yaroslav Winter</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Alzheimer Disease Research Unit and Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Research Center for Neurological Diseases (CIEN) Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofia Foundation, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, University of Rochester Medical Center, New York, Rochester</wicri:regionArea><wicri:noRegion>Rochester</wicri:noRegion></affiliation></author><author><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name><affiliation wicri:level="1"><country xml:lang="fr">Portugal</country><wicri:regionArea>Clinical Pharmacology and Therapeutics, Faculdade de Medicina de Lisboa, Lisbon</wicri:regionArea><wicri:noRegion>Lisbon</wicri:noRegion></affiliation></author><author><name sortKey="Ruzi Ka, Evzen" sort="Ruzi Ka, Evzen" uniqKey="Ruzi Ka E" first="Evžen" last="Růži Ka">Evžen Růži Ka</name><affiliation wicri:level="3"><country xml:lang="fr">République tchèque</country><wicri:regionArea>Department of Neurology, First Medical Faculty, Charles University in Prague, Prague</wicri:regionArea><placeName><settlement type="city">Prague</settlement><region type="région" nuts="2">Bohême centrale</region></placeName></affiliation></author><author><name sortKey="Hawthorne, Graeme" sort="Hawthorne, Graeme" uniqKey="Hawthorne G" first="Graeme" last="Hawthorne">Graeme Hawthorne</name><affiliation wicri:level="4"><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Psychiatry, The University of Melbourne, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region><settlement type="city">Melbourne</settlement></placeName><orgName type="university">Université de Melbourne</orgName></affiliation></author><author><name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, Philipps‐University Marburg, Marburg</wicri:regionArea><placeName><region type="land" nuts="1">Hesse (Land)</region><region type="district" nuts="2">District de Giessen</region><settlement type="city">Marbourg</settlement></placeName></affiliation></author><author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name><affiliation wicri:level="4"><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, Medical University of Innsbruck, Innsbruck</wicri:regionArea><orgName type="university">Université de médecine d'Innsbruck</orgName><placeName><settlement type="city">Innsbruck</settlement><region nuts="2" type="region">Tyrol (Land)</region></placeName><placeName><settlement type="city">Innsbruck</settlement><region nuts="2" type="region">Tyrol (Land)</region></placeName><orgName type="university">Université de médecine d'Innsbruck</orgName></affiliation></author><author><name sortKey="Stebbins, Glenn" sort="Stebbins, Glenn" uniqKey="Stebbins G" first="Glenn" last="Stebbins">Glenn Stebbins</name><affiliation wicri:level="3"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Illinois, Chicago</wicri:regionArea><placeName><settlement type="city">Chicago</settlement><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Rascol, Oliver" sort="Rascol, Oliver" uniqKey="Rascol O" first="Oliver" last="Rascol">Oliver Rascol</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Pharmacologie Medicale et Clinique, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><affiliation wicri:level="3"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurological Sciences, Rush University Medical Center, Illinois, Chicago</wicri:regionArea><placeName><settlement type="city">Chicago</settlement><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name><affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Neurology, University College London, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Movement Disorders</title><title level="j" type="alt">MOVEMENT DISORDERS</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><biblScope unit="vol">29</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="169">169</biblScope><biblScope unit="page" to="176">176</biblScope><biblScope unit="page-count">8</biblScope><date type="published" when="2014-02">2014-02</date></imprint><idno type="ISSN">0885-3185</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Health economic studies in Parkinson's disease (PD) have become increasingly common in recent years. Because several methodologies and instruments have been used to assess cost and outcomes in PD, the Movement Disorder Society (MDS) commissioned a Task Force to assess their properties and make recommendations regarding their use. A systematic literature review was conducted to explore the use of those instruments in PD and to determine which should be selected for this review. We assessed approaches to evaluate cost of illness (COI), cost effectiveness, and cost utilities, which include the use of direct (standard gamble, time trade‐off. and visual analogue scales) and indirect instruments to measure health status and utilities. No validated instruments/models were identified for the evaluation of COI or cost‐effectiveness in patients with PD; therefore, no instruments in this group are recommended. Among utility instruments, only a few of these outcome instruments have been used in the PD population, and only limited psychometric data are available for these instruments with respect to PD. Because psychometric data for further utility instruments in conditions other than PD already exist, the standard gamble and time trade‐off methods and the EQ‐5D (a European quality‐of‐life health states instrument) and Health Utility Index instruments met the criteria for scales that are “recommended (with limitations),” but only the EQ‐5D has been assessed in detail in PD patients. The MDS Task Force recommends further study of these instruments in the PD population to establish core psychometric properties. For the assessment of COI, the Task Force considers the development of a COI instrument specifically for PD, like that available for Alzheimer's disease. © 2013 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Australie</li><li>Autriche</li><li>Espagne</li><li>France</li><li>Portugal</li><li>Royaume-Uni</li><li>République tchèque</li><li>Suède</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Bohême centrale</li><li>Communauté de Madrid</li><li>District de Giessen</li><li>Grand Londres</li><li>Hesse (Land)</li><li>Illinois</li><li>Midi-Pyrénées</li><li>Occitanie (région administrative)</li><li>Svealand</li><li>Tyrol (Land)</li><li>Victoria (État)</li></region><settlement><li>Chicago</li><li>Innsbruck</li><li>Londres</li><li>Madrid</li><li>Marbourg</li><li>Melbourne</li><li>Prague</li><li>Stockholm</li><li>Toulouse</li></settlement><orgName><li>University College de Londres</li><li>Université de Melbourne</li><li>Université de médecine d'Innsbruck</li></orgName></list><tree><country name="Allemagne"><region name="Hesse (Land)"><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name></region><name sortKey="Dodel, Richard" sort="Dodel, Richard" uniqKey="Dodel R" first="Richard" last="Dodel">Richard Dodel</name><name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name><name sortKey="Reese, Jens Peter" sort="Reese, Jens Peter" uniqKey="Reese J" first="Jens Peter" last="Reese">Jens Peter Reese</name><name sortKey="Winter, Yaroslav" sort="Winter, Yaroslav" uniqKey="Winter Y" first="Yaroslav" last="Winter">Yaroslav Winter</name></country><country name="Suède"><region name="Svealand"><name sortKey="Jonsson, Bengt" sort="Jonsson, Bengt" uniqKey="Jonsson B" first="Bengt" last="Jönsson">Bengt Jönsson</name></region></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Martinez Artin, Pablo" sort="Martinez Artin, Pablo" uniqKey="Martinez Artin P" first="Pablo" last="Martinez-Martin">Pablo Martinez-Martin</name></region></country><country name="États-Unis"><noRegion><name sortKey="Holloway, Robert" sort="Holloway, Robert" uniqKey="Holloway R" first="Robert" last="Holloway">Robert Holloway</name></noRegion><name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G." last="Goetz">Christopher G. Goetz</name><name sortKey="Stebbins, Glenn" sort="Stebbins, Glenn" uniqKey="Stebbins G" first="Glenn" last="Stebbins">Glenn Stebbins</name></country><country name="Portugal"><noRegion><name sortKey="Sampaio, Cristina" sort="Sampaio, Cristina" uniqKey="Sampaio C" first="Cristina" last="Sampaio">Cristina Sampaio</name></noRegion></country><country name="République tchèque"><region name="Bohême centrale"><name sortKey="Ruzi Ka, Evzen" sort="Ruzi Ka, Evzen" uniqKey="Ruzi Ka E" first="Evžen" last="Růži Ka">Evžen Růži Ka</name></region></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Hawthorne, Graeme" sort="Hawthorne, Graeme" uniqKey="Hawthorne G" first="Graeme" last="Hawthorne">Graeme Hawthorne</name></region></country><country name="Autriche"><region name="Tyrol (Land)"><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name></region></country><country name="France"><region name="Occitanie (région administrative)"><name sortKey="Rascol, Oliver" sort="Rascol, Oliver" uniqKey="Rascol O" first="Oliver" last="Rascol">Oliver Rascol</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D65 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D65 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:81A07A161F130CB26F7F83520A40996C7826FB8E
|texte= Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease
}}
| This area was generated with Dilib version V0.6.33. |  |